L‐dopa increases α‐synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Increasing gene dosages of α‐synuclein induce familial Parkinson's disease (PD); thus, the hypothesis has been put forward that regulation of gene expression, in particular altered α‐synuclein gene methylation, might be associated with sporadic PD and could be used as a biological marker. Methods: We performed a thorough analysis of α‐synuclein methylation in bisulfite‐treated DNA from peripheral blood of 490 sporadic PD patients and 485 healthy controls and in addition analyzed the effect of levodopa (l‐dopa) on α‐synuclein methylation and expression in cultured mononuclear cells. Results: α‐Synuclein was hypomethylated in sporadic PD patients, correlated with sex, age, and a polymorphism in the analyzed sequence stretch (rs3756063). α‐Synuclein methylation separated healthy individuals from sporadic PD with a specificity of 74% (male) and 78% (female), respectively. α‐Synuclein methylation was increased in sporadic PD patients with higher l‐dopa dosage, and l‐dopa specifically induced methylation of α‐synuclein intron 1 in cultured mononuclear cells. Conclusions: α‐Synuclein methylation levels depended on disease status, sex, age, and the genotype of rs3756063. The pharmacological action of l‐dopa was not limited to the dopamine precursor function but included epigenetic off‐target effects. The hypomethylation of α‐synuclein in sporadic PD patients' blood already observed in previous studies was probably underestimated because of effect of l‐dopa, which was not known previously. The analysis of α‐synuclein methylation can help to identify nonparkinsonian individuals with reasonable specificity, which offers a valuable tool for researchers and clinicians. © 2015 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide methylation profiles reveal quantitative views of human aging rates
Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.016 · Cited by 4,270 · cited 1×
“correlation of methylation and human aging in blood, including sex-specific aging differences, which could underly the differential methylation of SNCA as well.(20) 2.”
BackgroundEpidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743 · cited 1×
“a cytosine and a guanine separated by only one phosphate.(7) Unmethylated CpGs are predominantly clustered in islands within promoter regions, usually allowing gene expression, whereas the dispersed methylated intragenic CpGs reduce the generation of aberrant transcripts.”
BackgroundParental olfactory experience influences behavior and neural structure in subsequent generations
Dias, B. G., & Ressler, K. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3594 · Cited by 1,338 · cited 1×
“DNA methylation is a relatively stable biochemical modification but it may be subject to dynamic changes during life, especially during early developmental stages, and it could be associated with a particular disease state.(9) We had put forward the hypothesis that an inherited or acquired epigenetic mark, or altered…”
BackgroundPrediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630
Cited by
CpG and non-CpG methylation in epigenetic gene regulation and brain function
Jang, H., Shin, W., Lee, J., & Do, J. (2017) · Genes · doi:10.3390/genes8060148 · Cited by 427
“Parkinson’s disease CpG methylation Hypomethylation of SNCA [130] CpG methylation Hypomethylation of TNF-αpromoter [134] CpG/non-CpG methylation Hypomethylation of mitochondrial DNA [102]”
BackgroundInfluentialDNA methylation in Parkinson's disease
Wüllner, U., Kaut, O., deBoni, L., Piston, D., & Schmitt, I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13646 · Cited by 107
Self-citationde Boni, L., Gasparoni, G., Haubenreich, C., Tierling, S., Schmitt, I., Peitz, M., Koch, P., Walter, J., Wüllner, U., & Brüstle, O. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0440-0 · Cited by 47
“ESC and iPSC were analyzed as described elsewhere [33].”
Method
Metadata
- Authors
- Schmitt, I., Kaut, O., Khazneh, H., deBoni, L., Ahmad, A., Berg, D., Klein, C., Fröhlich, H., & Wüllner, U.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2015-07-14
- Volume
- 30
- Issue
- 13
- Pages
- 1794-1801
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1555034521
- Cited by
- 101
- References
- 6
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: L‐dopa increases α‐synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro. https://app.cochat.ai/papers/10.1002/mds.26319
- The paper
- Schmitt, I., Kaut, O., Khazneh, H., deBoni, L., Ahmad, A., Berg, D., Klein, C., Fröhlich, H., & Wüllner, U. (2015). L‐dopa increases α‐synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro. Movement Disorders. https://doi.org/10.1002/mds.26319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.